| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviridae | 25 | 2020 | 579 | 2.220 |
Why?
|
| Genetic Vectors | 25 | 2023 | 892 | 2.130 |
Why?
|
| Genetic Therapy | 20 | 2020 | 713 | 1.990 |
Why?
|
| Receptors, LDL | 14 | 2016 | 106 | 1.550 |
Why?
|
| Helper Viruses | 6 | 2008 | 45 | 0.790 |
Why?
|
| Heart Failure | 9 | 2025 | 2332 | 0.730 |
Why?
|
| Liver | 18 | 2015 | 1796 | 0.650 |
Why?
|
| Atherosclerosis | 8 | 2015 | 948 | 0.610 |
Why?
|
| Gene Transfer Techniques | 12 | 2020 | 344 | 0.590 |
Why?
|
| Retina | 2 | 2020 | 425 | 0.580 |
Why?
|
| Frailty | 3 | 2025 | 140 | 0.530 |
Why?
|
| Apolipoprotein A-I | 6 | 2015 | 80 | 0.520 |
Why?
|
| Hyperlipidemias | 4 | 2004 | 185 | 0.520 |
Why?
|
| Hyperlipoproteinemia Type II | 4 | 2014 | 119 | 0.500 |
Why?
|
| Islets of Langerhans | 6 | 2015 | 163 | 0.470 |
Why?
|
| Cachexia | 3 | 2024 | 57 | 0.450 |
Why?
|
| Cholesterol | 9 | 2016 | 539 | 0.430 |
Why?
|
| Sarcopenia | 3 | 2024 | 56 | 0.420 |
Why?
|
| Frail Elderly | 2 | 2025 | 107 | 0.410 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 184 | 0.400 |
Why?
|
| Apolipoproteins E | 6 | 2015 | 187 | 0.390 |
Why?
|
| Macrophages | 5 | 2015 | 667 | 0.350 |
Why?
|
| Mice | 43 | 2016 | 18301 | 0.340 |
Why?
|
| Interleukin-7 | 1 | 2011 | 46 | 0.340 |
Why?
|
| RNA, Messenger | 15 | 2014 | 2550 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2015 | 137 | 0.310 |
Why?
|
| Monocytes | 1 | 2011 | 335 | 0.300 |
Why?
|
| Animals | 50 | 2016 | 33912 | 0.290 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 468 | 0.280 |
Why?
|
| Lipase | 5 | 2000 | 91 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 19 | 2016 | 4738 | 0.270 |
Why?
|
| Dependovirus | 3 | 2023 | 160 | 0.270 |
Why?
|
| Prognosis | 10 | 2025 | 4886 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 4 | 2015 | 1075 | 0.260 |
Why?
|
| Cell Line | 8 | 2020 | 2552 | 0.250 |
Why?
|
| Arteriosclerosis | 5 | 2006 | 109 | 0.250 |
Why?
|
| Hypoalphalipoproteinemias | 1 | 2006 | 1 | 0.250 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 1211 | 0.240 |
Why?
|
| Mice, Knockout | 17 | 2016 | 3819 | 0.230 |
Why?
|
| Cytidine Deaminase | 5 | 2000 | 31 | 0.230 |
Why?
|
| Transduction, Genetic | 4 | 2014 | 276 | 0.210 |
Why?
|
| Apolipoproteins B | 6 | 2000 | 142 | 0.210 |
Why?
|
| Genetic Techniques | 1 | 2005 | 95 | 0.210 |
Why?
|
| Lipoproteins, VLDL | 4 | 2006 | 53 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 1459 | 0.210 |
Why?
|
| Lipoproteins, LDL | 4 | 2009 | 119 | 0.200 |
Why?
|
| Transgenes | 5 | 2009 | 316 | 0.200 |
Why?
|
| Capsid | 1 | 2023 | 93 | 0.200 |
Why?
|
| Base Sequence | 15 | 2011 | 2730 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2014 | 209 | 0.180 |
Why?
|
| Down-Regulation | 4 | 2016 | 645 | 0.180 |
Why?
|
| Nutritional Status | 1 | 2024 | 298 | 0.180 |
Why?
|
| Transcription, Genetic | 4 | 2011 | 1363 | 0.180 |
Why?
|
| Lipoprotein Lipase | 5 | 2000 | 60 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 1997 | 242 | 0.180 |
Why?
|
| Cause of Death | 1 | 2024 | 506 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 450 | 0.170 |
Why?
|
| Molecular Sequence Data | 15 | 2004 | 3464 | 0.170 |
Why?
|
| Humans | 42 | 2025 | 131163 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2016 | 895 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2016 | 2885 | 0.160 |
Why?
|
| Neurons | 2 | 2014 | 1979 | 0.160 |
Why?
|
| Betacellulin | 3 | 2015 | 5 | 0.160 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2020 | 22 | 0.150 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 710 | 0.150 |
Why?
|
| Retinitis Pigmentosa | 1 | 2020 | 77 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 549 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 5 | 2011 | 1207 | 0.140 |
Why?
|
| RNA Editing | 3 | 2000 | 31 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2025 | 6797 | 0.140 |
Why?
|
| Hypercholesterolemia | 2 | 2016 | 230 | 0.140 |
Why?
|
| Gene Expression | 7 | 2015 | 1481 | 0.140 |
Why?
|
| Female | 24 | 2025 | 70963 | 0.140 |
Why?
|
| Cell Movement | 2 | 2013 | 876 | 0.140 |
Why?
|
| Eye Proteins | 1 | 2020 | 221 | 0.140 |
Why?
|
| Amino Acid Sequence | 11 | 2000 | 2395 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2020 | 801 | 0.130 |
Why?
|
| Brain | 1 | 2009 | 3175 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 150 | 0.120 |
Why?
|
| Integrases | 3 | 2009 | 157 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 124 | 0.120 |
Why?
|
| Male | 23 | 2025 | 64957 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2024 | 6459 | 0.120 |
Why?
|
| Perilipin-2 | 1 | 2015 | 11 | 0.120 |
Why?
|
| Glucokinase | 1 | 1995 | 13 | 0.120 |
Why?
|
| Foam Cells | 1 | 2015 | 21 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 25 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2016 | 423 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 223 | 0.110 |
Why?
|
| DNA Primers | 4 | 2011 | 599 | 0.110 |
Why?
|
| Injections, Intra-Arterial | 1 | 2014 | 17 | 0.110 |
Why?
|
| Biomarkers | 1 | 2024 | 3385 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 664 | 0.110 |
Why?
|
| Hepatic Artery | 1 | 2014 | 45 | 0.110 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 7 | 0.110 |
Why?
|
| Balloon Occlusion | 1 | 2014 | 48 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 262 | 0.100 |
Why?
|
| Biological Evolution | 2 | 1995 | 222 | 0.100 |
Why?
|
| Meiosis | 1 | 2014 | 111 | 0.100 |
Why?
|
| Japan | 2 | 2024 | 161 | 0.100 |
Why?
|
| Lentivirus | 1 | 2014 | 80 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 109 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 288 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2014 | 50 | 0.100 |
Why?
|
| Ganglia, Spinal | 2 | 2014 | 65 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 150 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 136 | 0.100 |
Why?
|
| Neuralgia | 1 | 2014 | 48 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 5 | 2005 | 1447 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 268 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2015 | 234 | 0.100 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 2323 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2014 | 504 | 0.090 |
Why?
|
| Aged | 8 | 2025 | 21025 | 0.090 |
Why?
|
| Appetite | 1 | 2013 | 35 | 0.090 |
Why?
|
| Transfection | 3 | 2012 | 962 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2009 | 307 | 0.090 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2011 | 13 | 0.090 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 8 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2011 | 825 | 0.090 |
Why?
|
| CREB-Binding Protein | 1 | 2011 | 54 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 639 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2013 | 206 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 112 | 0.080 |
Why?
|
| Tauopathies | 1 | 2011 | 72 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 133 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 950 | 0.080 |
Why?
|
| Rabbits | 4 | 1997 | 575 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 223 | 0.080 |
Why?
|
| Mutation | 5 | 2014 | 6099 | 0.080 |
Why?
|
| Dietary Fats | 2 | 2008 | 278 | 0.080 |
Why?
|
| DNA, Complementary | 6 | 1997 | 422 | 0.080 |
Why?
|
| Cholesterol, Dietary | 4 | 2015 | 49 | 0.080 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2009 | 2 | 0.080 |
Why?
|
| Sandhoff Disease | 1 | 2009 | 4 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 335 | 0.080 |
Why?
|
| Disease Models, Animal | 8 | 2016 | 4697 | 0.070 |
Why?
|
| Lipoproteins, IDL | 1 | 2009 | 6 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2011 | 440 | 0.070 |
Why?
|
| Time Factors | 6 | 2024 | 6196 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1801 | 0.070 |
Why?
|
| Venoms | 1 | 2008 | 17 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 544 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2016 | 358 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2009 | 175 | 0.070 |
Why?
|
| Aorta | 5 | 2015 | 521 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 187 | 0.070 |
Why?
|
| APOBEC-1 Deaminase | 5 | 2000 | 11 | 0.070 |
Why?
|
| Models, Animal | 2 | 2006 | 450 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2009 | 232 | 0.060 |
Why?
|
| Diet, Atherogenic | 3 | 2009 | 14 | 0.060 |
Why?
|
| Hypertension | 2 | 2006 | 1356 | 0.060 |
Why?
|
| Autoantibodies | 2 | 2009 | 451 | 0.060 |
Why?
|
| Prevalence | 2 | 2024 | 2701 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2009 | 190 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 530 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2006 | 11 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2009 | 401 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 109 | 0.060 |
Why?
|
| Astrocytes | 1 | 2009 | 264 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 300 | 0.060 |
Why?
|
| Phenotype | 3 | 2023 | 4497 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 445 | 0.060 |
Why?
|
| Smad3 Protein | 1 | 2006 | 53 | 0.060 |
Why?
|
| Chromosome Mapping | 4 | 1996 | 1046 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2005 | 203 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 45 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2006 | 131 | 0.060 |
Why?
|
| Organ Specificity | 3 | 2013 | 394 | 0.060 |
Why?
|
| Cerebellum | 1 | 2009 | 441 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 39 | 0.060 |
Why?
|
| Peptides | 1 | 2008 | 708 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2009 | 760 | 0.050 |
Why?
|
| Quality Control | 1 | 2005 | 116 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 3711 | 0.050 |
Why?
|
| Viral Load | 1 | 2006 | 416 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 223 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 299 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2024 | 118 | 0.050 |
Why?
|
| Stem Cells | 1 | 2009 | 702 | 0.050 |
Why?
|
| Ultracentrifugation | 1 | 2023 | 20 | 0.050 |
Why?
|
| Hand Strength | 1 | 2023 | 59 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2023 | 129 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2005 | 337 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2012 | 2406 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 573 | 0.050 |
Why?
|
| Rats | 5 | 1997 | 3370 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2014 | 4686 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2024 | 344 | 0.050 |
Why?
|
| Lipoproteins | 2 | 2001 | 183 | 0.050 |
Why?
|
| Plasmids | 2 | 2001 | 449 | 0.050 |
Why?
|
| Malnutrition | 1 | 2024 | 163 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2005 | 256 | 0.040 |
Why?
|
| Virus Replication | 1 | 2005 | 608 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2011 | 2326 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1995 | 780 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 633 | 0.040 |
Why?
|
| Spleen | 2 | 2014 | 258 | 0.040 |
Why?
|
| Pedigree | 3 | 2014 | 1677 | 0.040 |
Why?
|
| Heart | 3 | 2005 | 650 | 0.040 |
Why?
|
| Adipose Tissue | 3 | 1999 | 502 | 0.040 |
Why?
|
| Obesity | 2 | 2013 | 2426 | 0.040 |
Why?
|
| Glucose | 3 | 2012 | 853 | 0.040 |
Why?
|
| Lipoproteins, HDL | 2 | 2015 | 97 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1995 | 623 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 541 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1722 | 0.040 |
Why?
|
| Insulin | 3 | 2015 | 1149 | 0.040 |
Why?
|
| Age Factors | 2 | 2024 | 2825 | 0.040 |
Why?
|
| DNA | 3 | 2009 | 1399 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 787 | 0.040 |
Why?
|
| Liposomes | 1 | 2000 | 201 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 1267 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 72 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 11074 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2011 | 1013 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 2085 | 0.040 |
Why?
|
| Gene Library | 2 | 1995 | 212 | 0.030 |
Why?
|
| HeLa Cells | 2 | 1996 | 686 | 0.030 |
Why?
|
| Propranolol | 1 | 1997 | 110 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2016 | 14 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 1996 | 12 | 0.030 |
Why?
|
| Cell Extracts | 1 | 1996 | 14 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1996 | 26 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2016 | 40 | 0.030 |
Why?
|
| Apoptosis | 2 | 2014 | 1827 | 0.030 |
Why?
|
| Phylogeny | 2 | 2000 | 689 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 81 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1996 | 66 | 0.030 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2016 | 28 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 127 | 0.030 |
Why?
|
| Antibodies | 1 | 1997 | 322 | 0.030 |
Why?
|
| Immunization | 1 | 1997 | 269 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 1996 | 74 | 0.030 |
Why?
|
| Sterol O-Acyltransferase | 1 | 1995 | 3 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1997 | 216 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 12 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2015 | 28 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 25 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1995 | 145 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1995 | 211 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5196 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 329 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2465 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 765 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 516 | 0.030 |
Why?
|
| Centromere | 1 | 2014 | 67 | 0.030 |
Why?
|
| Chromatids | 1 | 2014 | 32 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 1994 | 32 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1996 | 556 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2014 | 34 | 0.030 |
Why?
|
| Disease Progression | 3 | 2006 | 2200 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 273 | 0.030 |
Why?
|
| Body Weight | 2 | 2013 | 987 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 1993 | 54 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 224 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 229 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1993 | 50 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 195 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2013 | 52 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2013 | 8 | 0.020 |
Why?
|
| Diet | 1 | 2000 | 1121 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 981 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2014 | 145 | 0.020 |
Why?
|
| Exons | 2 | 1992 | 759 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 46 | 0.020 |
Why?
|
| Endotoxins | 1 | 1993 | 51 | 0.020 |
Why?
|
| Hyperphagia | 1 | 2013 | 42 | 0.020 |
Why?
|
| Chylomicrons | 1 | 1992 | 10 | 0.020 |
Why?
|
| Asparagine | 1 | 1992 | 22 | 0.020 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 1992 | 11 | 0.020 |
Why?
|
| Laser Capture Microdissection | 1 | 2012 | 9 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 89 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 743 | 0.020 |
Why?
|
| Tryptophan | 1 | 1992 | 84 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 371 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 412 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 448 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 500 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 1993 | 117 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 243 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 303 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 198 | 0.020 |
Why?
|
| Microglia | 1 | 2013 | 147 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 410 | 0.020 |
Why?
|
| DNA Repair | 1 | 2014 | 571 | 0.020 |
Why?
|
| Glutamine | 1 | 1992 | 200 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 273 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 83 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 690 | 0.020 |
Why?
|
| Models, Biological | 2 | 2009 | 1371 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 197 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 589 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 767 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1103 | 0.020 |
Why?
|
| Arginine | 1 | 1992 | 340 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 526 | 0.020 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2009 | 12 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 1591 | 0.020 |
Why?
|
| Receptors, Glucagon | 1 | 2008 | 33 | 0.020 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2008 | 44 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 57 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 1939 | 0.020 |
Why?
|
| Calgranulin B | 1 | 2008 | 8 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 978 | 0.020 |
Why?
|
| Myocardium | 3 | 1999 | 852 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 1999 | 234 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 715 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2009 | 357 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 38 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2006 | 21 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2006 | 37 | 0.010 |
Why?
|
| Hippocampus | 1 | 2011 | 806 | 0.010 |
Why?
|
| Eating | 1 | 2008 | 377 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2006 | 54 | 0.010 |
Why?
|
| Mifepristone | 1 | 2005 | 81 | 0.010 |
Why?
|
| Cricetinae | 2 | 1996 | 362 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 387 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17753 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2005 | 90 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2009 | 919 | 0.010 |
Why?
|
| Homeostasis | 1 | 2009 | 712 | 0.010 |
Why?
|
| Organ Size | 1 | 2005 | 407 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 71 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 300 | 0.010 |
Why?
|
| Species Specificity | 2 | 1995 | 470 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1205 | 0.010 |
Why?
|
| Lipids | 2 | 1997 | 569 | 0.010 |
Why?
|
| Time | 1 | 2003 | 92 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 975 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1997 | 1105 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 383 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1928 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2001 | 226 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2001 | 63 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2000 | 74 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 2000 | 69 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1345 | 0.010 |
Why?
|
| RNA Probes | 1 | 1999 | 25 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 76 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 110 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 241 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 3436 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 27 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 67 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1997 | 130 | 0.010 |
Why?
|
| Middle Aged | 2 | 2009 | 28601 | 0.010 |
Why?
|
| Triglycerides | 1 | 2000 | 602 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1997 | 295 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1996 | 36 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1997 | 341 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 31282 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 254 | 0.010 |
Why?
|
| Epitopes | 1 | 1997 | 324 | 0.010 |
Why?
|
| CHO Cells | 1 | 1996 | 152 | 0.010 |
Why?
|
| Nucleotide Deaminases | 1 | 1995 | 1 | 0.010 |
Why?
|
| Nucleoside Deaminases | 1 | 1995 | 23 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2000 | 1117 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 235 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1995 | 198 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 1996 | 235 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 422 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 308 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1995 | 732 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1995 | 291 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1994 | 582 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 167 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 93 | 0.010 |
Why?
|
| Binding Sites | 1 | 1994 | 1133 | 0.010 |
Why?
|
| Introns | 1 | 1992 | 278 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1993 | 299 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 20987 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1993 | 359 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1993 | 327 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 12936 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 7512 | 0.000 |
Why?
|